Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 21Lymphoid 12Gastrointestinal 9Thoracic 2Other hematologic neoplasm 2Tumor-Agnostic 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1

Interventions

Carboplatin 1174Cisplatin 891Pemetrexed 847pembrolizumab 626Paclitaxel 609Docetaxel 539Gemcitabine 428Radiotherapy 393Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 297durvalumab 264Drug Therapy 260osimertinib 237atezolizumab 225Radiosurgery 196Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 132Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Clarithromycin × Thoracic × Clear all
NCT02852083 2018-01-18

ModuLung

University Hospital Regensburg

Phase 2 Unknown
86 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02416570 2016-09-16

Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer?

University of Nottingham

Phase 2 Terminated
1 enrolled
Thoracic

Cachexia, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡